OsteoporeASX:OSX Gross Margin % is 78.50% as of Dec. 2025, which is 6% above its 10-year median of 73.79. The stock has 7 warning signs investors should review. Among 805 Medical Devices & Instruments companies, Osteopore ranks better than 88.82% on this metric.
Gross Margin % is calculated as gross profit divided by its revenue. Osteopore's Gross Profit for the
six
months ended in Dec. 2025 was A$1.18 Mil. Osteopore's Revenue for the
six
months ended in Dec. 2025 was A$1.50 Mil. Therefore, Osteopore's Gross Margin % for the quarter that ended in Dec. 2025 was 78.50%.
The historical rank and industry rank for Osteopore's Gross Margin % or its related term are showing as below:
ASX:OSX'
s Gross Margin % Range Over the Past 10 Years
Min: 63.46 Med: 73.79 Max: 83.96
Current: 77.49
During the past 8 years, the highestGross Margin % of Osteopore was 83.96%. The lowest was 63.46%. And the median was 73.79%.
ASX:OSX's Gross Margin % is ranked better than 88.82% of 805
companies
in the Medical Devices & Instruments industry
Industry Median: 52.07
vs ASX:OSX: 77.49
Osteopore had a gross margin of 78.50% for the quarter that ended in Dec. 2025 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for Osteopore was 4.10% per year.
Osteopore (ASX:OSX) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Osteopore had a gross margin of 78.50% for the quarter that ended in Dec. 2025 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Osteopore Gross Margin % Related Terms
Osteopore Gross Margin % Historical Data
* Premium members only.
The historical data trend for Osteopore's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ASX:OSX vs ISRG, BDX, MDLN: Gross Margin % Comparison
For the Medical Instruments & Supplies subindustry, Osteopore's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Osteopore Gross Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Osteopore's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Osteopore's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Osteopore (ASX:OSX) has a Gross Margin % of 78.50% as of Dec. 2025. Gross margin is the ratio of total gross profit to net sales. View historical data on Osteopore and its competitors. This is near median its historical median of 73.79. Over the past decade, Osteopore's Gross Margin % has ranged from 63.46 to 83.96. According to the industry distribution chart, Osteopore ranks #90 out of 805 companies in the Medical Devices & Instruments industry, placing it in the top 11.2%.
Is Osteopore's Gross Margin % too high?
Osteopore's current Gross Margin % of 78.50% is near median its 10-year median of 73.79. Over the past 10 years, this metric has ranged from a low of 63.46 to a high of 83.96. The Medical Devices & Instruments industry median Gross Margin % is 52.07. Osteopore's value of 78.50% is 50.8% above this industry median. Based on the distribution chart, Osteopore ranks #90 out of 805 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers.
How does Osteopore's Gross Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Osteopore ranks #90 out of 805 companies for Gross Margin %. This places Osteopore in the top 11% of its industry — outperforming the majority of peers. The industry median Gross Margin % is 52.07. Osteopore's value of 78.50% is 50.8% above this benchmark. Historically, Osteopore's own Gross Margin % has ranged from 63.46 to 83.96 over the past decade. While the company's 10-year median is 73.79 vs. the industry median of 52.07, Osteopore has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Medical Devices & Instruments company?
The median Gross Margin % among Medical Devices & Instruments companies is 52.07, based on 805 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Osteopore's current Gross Margin % of 78.50% is 50.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Osteopore and its competitors. For the Medical Devices & Instruments industry, the median Gross Margin % is 52.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Osteopore's current Gross Margin % is 78.50%, which is near median its own 10-year median of 73.79. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Osteopore stock overvalued right now?
Based on GuruFocus' analysis, Osteopore (ASX:OSX) is currently considered Possible Value Trap. The stock's GF Value™ is A$0.02, compared to a current price of A$0.00 — trading 80% below its estimated fair value. The current Gross Margin % is 78.50%, which is near median its 10-year median of 73.79 and 50.8% above the Medical Devices & Instruments industry median of 52.07. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Osteopore (ASX:OSX), the current Gross Margin % is 78.50% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Osteopore Ltd is engaged in the production of 3D-printed bioresorbable implants that are used in conjunction with surgical procedures to assist bone healing. Its products include Osteoplug, which is a bioresorbable implant used for covering trephination burr holes in neurosurgery, and Osteomesh which is a bioresorbable implant used in craniofacial surgery. It operate in the high-growth regenerative medicine sector, where adoption continues to rise as healthcare systems increasingly embrace developed tissue-regenerative solutions. Business operating segments are based on the firm's geographical presence in Singapore and Australia.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:OSX has been successfully added to your 